Respiratory Failure (Pediatric Patients)
Conditions
Brief summary
The investigators developed an index that integrates different flow-settings in High-flow nasal cannula (HFNC) therapy with non-invasively measured clinical parameters of oxygenation in pediatric patients. This observational study is designed to evaluate this index and to determine a cut-off value for imminent HFNC failure.
Detailed description
High-flow nasal cannula therapy is a broadly used instrument of respiratory support in pediatric and adult patients with respiratory failure. For adult patients with pneumonia and respiratory failure, there is a validated index (ROX; ratio SpO2/FiO2) which helps to identify those at risks for the need of intubation. This index however is not applicable in the pediatric population because the physiological values of respiratory rate vary greatly across different ages. Thus, based on the particularities of pediatric patients the investigators developed an index that integrates different flow-settings in HFNC therapy with non-invasively measured clinical parameters of oxygenation. The BPOI is defined as the ratio of the product of the peripherally measured oxygen saturation and the patient's body weight divided by the product of HFNC flow and the fraction of inspired oxygen: BPOI = (SpO2 \* kg) / (Flow \* FiO2)
Interventions
None listed
Sponsors
Charite University, Berlin, Germany
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
28 Days to 17 Years
Healthy volunteers
No
Inclusion criteria
* Patients with respiratory failure and indication für High-flow nasal cannula therapy * Patients aged between 4 1/7 weeks and 18 years * Patients who were treated between 01/01/2017 and 28/02/2021 in the Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine at Campus Virchow- Klinikum, Charité - Universitätsmedizin Berlin
Exclusion criteria
* Patients aged between 1 and 27 days (neonatal period) * Patients with congenital cyanotic heart defects * Patients after or in the course of haematopoetic stem cell transplantation * Patients with ambulatory respiratory support
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| BPOI (Berlin Pediatric Oxygenation Index) | 01.01.2017-28.02.2021 | Evaluation of a certain cut-off value for the BPOI (Berlin Pediatric Oxygenation Index) that predicts imminent failure of high-flow nasal cannula (HFNC) therapy in paediatric patients. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Heart rate | 01.01.2017-28.02.2021 | Measurement of heart rate at given time points |
| Blood pressure (mean arterial pressure, MAP) | 01.01.2017-28.02.2021 | Measurement of blood pressure at given time points |
| Intensive care unit length of stay | 01.01.2017-28.02.2021 | Time period until the patient is either deferred to another non-ICU or until end of treatment period/death |
| Respiratory rate | 01.01.2017-28.02.2021 | Measurement of respiratory rate at given time points |
| Need for intubation | 01.01.2017-28.02.2021 | High-flow nasal cannula (HFNC) or non-invasively ventilation (NIV failure) |
| Need for mechanical ventilation | 01.01.2017-28.02.2021 | Need for assisted or controlled ventilation |
| High-flow nasal cannula therapy failure | 01.01.2017-28.02.2021 | Count of days until the respiratory therapy is escalated to non-invasive ventilation after the cut-off value for the BPOI has been reached. |
Outcome results
None listed